New Reports Recently Added to Healthcare Catalogue
27 Mar 2023 • by Natalie Aster
LONDON – Market Publishers has a sizeable collection of in-demand reports covering the healthcare market, which is regularly replenished with cutting-edge publications from our research partners. These studies provide a clear understanding of the examined markets landscape, give access to reliable data on historical and current scenarios, discuss prevailing and emerging trends, identify the major growth opportunities and challenges, outline future growth prospects, delve into the competitive environment, point out top players, uncover cutting-edge statistics and market data, and offer other important information on the market performance. Here is a selection of the most popular research reports on the healthcare market recently added at MarketPublishers.com:
The value of the global allergy treatment market is forecast to grow from USD 19.69 billion in 2021 to USD 28.78 billion by 2027, registering a CAGR of 6.2% in the next 5 years. The rising prevalence of different allergies across the world acts as the major driver of this market. Besides, favourable initiatives undertaken by governments and non-governmental organizations to inform people about the adversities of allergies and appropriate treatment options are bolstering the market growth. Moreover, the mounting demand for over-the-counter (OTC) drugs along with the increasing inclination toward self-medication among consumers also act as market growth engines. Other important drivers of the allergy treatment market include the growing penetration of advanced technologies, rising demand for subcutaneous allergen-specific immunotherapy (SCIT), increasing healthcare expenditures, extensive R&D activities toward novel treatments, and rising incidences of asthma…
Today, diagnostic imaging is widely adopted by healthcare practitioners to examine patients and make a diagnosis of their exact medical conditions. In 2021, the value of the global diagnostic imaging market reached around USD 26.6 billion. This market is slated for healthy growth between 2023 and 2029 with an anticipated CAGR of over 5.7%. The soaring demand for early disease diagnosis, increasing scope of clinical applications, growing investments and funding by public-private organizations, constantly increasing geriatric population, and a subsequent rise in the prevalence of associated diseases (for example cancer and gastrointestinal issues, among others) are the few factors that are expected to drive the market growth over the forecast period. Geographically, the dominant share of the global diagnostic imaging market is expected to be held by North America in the next 6 years…
The global RNAi therapeutics market is slated for robust growth at a CAGR of slightly over 10% in the next 4 years, encouraged by the increasing prevalence of infectious diseases, rapidly aging population, rising incidence of neurodegenerative disorders, mounting demand in the oncology pharmaceuticals sector, and remarkable progress in collaborations and associated deals in the RNAi therapeutics field. Meantime, such challenges as some complexities associated with the drug delivery of RNAi therapeutics, stringent regulatory requirements, and high development costs of RNA interference-based therapeutics may restrain the RNAi therapeutics market growth in the coming years. In 2027, the value of the global RNAi therapeutics market is set to amount to USD 1.26 billion. The North American market is set to exhibit the highest growth rates through 2027…
Heart Failure Devices (HFD) Market
The world’s market for heart failure devices (HFD) is predicted to register high single-digit growth between 2023 and 2029 and cross the value of USD 38.87 billion by the year 2029. Robust market growth will likely be spurred by such factors as the rising incidence of heart failure diseases, ongoing technological breakthroughs in heart failure devices, growing funding, and the increasing number of approvals in this field. However, the market growth is poised to be hampered by a number of challenges, including certain complications associated with the implantation of heart failure devices, high prices for these devices, a lack of trained professionals, and stringent regulations in the sphere, among others. The structural heart device segment is predicted to hold the dominant market share and register the highest growth rates during 2023-2029…
Neuromodulation Devices Market
Neuromodulation devices are gaining popularity at a robust pace as these medical devices have proven to be very successful in the treatment of conditions for which medicines have failed completely or may have unpleasant side effects. The world’s market for neuromodulation devices is slated for robust growth at a high single-digit CAGR over 2023-2029 and is forecast to cross the USD 9.42 billion mark in terms of value in 2029. The increasing incidence of chronic pain conditions, CNS disorders (including Alzheimer’s disease, Parkinson’s disease, Epilepsy, and Multiple sclerosis, among others), low approval rates of CNS drugs, and favorable reimbursement scenarios in major markets are poised to act as the major market growth engines in the coming years. The invasive neuromodulation devices segment is anticipated to hold the largest revenue share of the overall market during 2023-2027…
Many other topical research studies can be found in the Healthcare Market Reports Catalogue.
Analytics & News
